Dendrimers as Drug and Gene Delivery Systems

2006 ◽  
pp. 489-508
Author(s):  
Jong-Sang Park ◽  
Tae-il Kim
Pharmaceutics ◽  
2021 ◽  
Vol 13 (7) ◽  
pp. 940
Author(s):  
Chaojie Zhu ◽  
Zhiheng Ji ◽  
Junkai Ma ◽  
Zhijie Ding ◽  
Jie Shen ◽  
...  

Cancer is one of the most devastating and ubiquitous human diseases. Conventional therapies like chemotherapy and radiotherapy are the most widely used cancer treatments. Despite the notable therapeutic improvements that these measures achieve, disappointing therapeutic outcome and cancer reoccurrence commonly following these therapies demonstrate the need for better alternatives. Among them, bacterial therapy has proven to be effective in its intrinsic cancer targeting ability and various therapeutic mechanisms that can be further bolstered by nanotechnology. In this review, we will discuss recent advances of nanotechnology-facilitated bacteria-based drug and gene delivery systems in cancer treatment. Therapeutic mechanisms of these hybrid nanoformulations are highlighted to provide an up-to-date understanding of this emerging field.


Biomaterials ◽  
2011 ◽  
Vol 32 (36) ◽  
pp. 9866-9875 ◽  
Author(s):  
Benjamin K.K. Teo ◽  
Seok-Hong Goh ◽  
Tanu S. Kustandi ◽  
Wei Wei Loh ◽  
Hong Yee Low ◽  
...  

2011 ◽  
Vol 149 (1) ◽  
pp. 65-71 ◽  
Author(s):  
Dakrong Pissuwan ◽  
Takuro Niidome ◽  
Michael B. Cortie

Author(s):  
Chun Chan ◽  
Shi Du ◽  
Yizhou Dong ◽  
Xiaolin Cheng

: Lipid nanoparticles (LNPs) have been widely applied for drug and gene delivery. More than twenty years ago, Doxil TM was the first LNPs-based drug approved by the US Food and Drug Administration (FDA). Since then, with decades of research and development, more and more LNP-based therapeutics have been used to treat diverse diseases, which often offer the benefits of reduced toxicity and/or enhanced efficacy compared to the active ingredients alone. Here, we provide a review on recent advances in the development of efficient and robust LNPs for drug/gene delivery. We emphasize the importance of rationally combining experimental and computational approaches, especially those providing multiscale structural and functional information of LNPs, to the design of novel and powerful LNP-based delivery systems.


2019 ◽  
Vol 23 (11) ◽  
pp. 1256-1269 ◽  
Author(s):  
Ramin Karimian ◽  
Milad Aghajani

Cyclodextrins (CDs) are naturally occurring cyclic oligosaccharides containing six (α-CD), seven (β-CD), eight (γ-CD) and more glucopyranose units linked with α-(1,4) bonds, having a terminal hydrophilic part and central lipophilic cavity. α-, β- and γ-CDs are widely used in many industrial products, technologies and analytical methods owing to their unique, versatile and tunable characteristics. In the pharmaceutical industry, CDs are used as complexing agents to enhance aqueous solubility, physico-chemical stability and bio-availability of administered drugs. Herein, special attention is given to the use of α-, β- and γ-CDs and their derivatives in different areas of drug and gene delivery systems in the past few decades through various routes of administration with a major emphasis on the more recent developments.


2014 ◽  
Vol 2014 ◽  
pp. 1-12 ◽  
Author(s):  
Patricia Marqués-Gallego ◽  
Anton I. P. M. de Kroon

Liposomes have been exploited for pharmaceutical purposes, including diagnostic imaging and drug and gene delivery. The versatility of liposomes as drug carriers has been demonstrated by a variety of clinically approved formulations. Since liposomes were first reported, research of liposomal formulations has progressed to produce improved delivery systems. One example of this progress is stealth liposomes, so called because they are equipped with a PEGylated coating of the liposome bilayer, leading to prolonged blood circulation and improved biodistribution of the liposomal carrier. A growing research area focuses on the preparation of liposomes with the ability of targeting specific tissues. Several strategies to prepare liposomes with active targeting ligands have been developed over the last decades. Herein, several strategies for the functionalization of liposomes are concisely summarized, with emphasis on recently developed technologies for the covalent conjugation of targeting ligands to liposomes.


Sign in / Sign up

Export Citation Format

Share Document